Allele Dmel\PvrDN.Scer\UAS
| General Information | |||
|---|---|---|---|
| Symbol | Dmel\PvrDN.Scer\UAS | Species | D. melanogaster |
| Name | FlyBase ID | FBal0127282 | |
| Feature type | allele | Associated gene | Dmel\Pvr |
| Also Known As | PVRDN | ||
| Allele class | antimorphic allele - genetic evidence | ||
| Mutagen | in vitro construct - deletion, in vitro construct - regulatory fusion | ||
Recent Updates
|
|||
| Description |
What does this section display?
This section contains items that were added to this record for each release.
It currently only tracks new links between this FlyBase report and other
FlyBase data classes (e.g. genes, references, stocks) or controlled
vocabulary terms (e.g. GO, anatomy terms).
What does this section not display?
This section does not currently display links that were removed or gene model changes.
|
||
| Update Feed |
Click the icon below to subscribe to this FlyBase record and receive updates automatically through your
feed reader.
|
||
| FB2013_03 | |||
| FB2013_02 | |||
| All updates | Click here to see a list of all updates to this record from FB2010_08 and on. | ||
Nature of the Allele
| |||
| Allele class | |||
| Mutagen | |||
| Mutations Mapped to the Genome | |||
Type Location Additional Notes References | |||
| Associated Sequence Data | |||
| DDBJ
/
EMBL / GenBank | DNA sequence Protein sequence Name | ||
| UniProtKB/Swiss-Prot | |||
| UniProtKB/TrEMBL | |||
| Progenitor genotype | |||
| Nature of the lesion | Statement Reference | ||
| Carried in construct | (Bianco et al., 2007, Sears et al., 2003, Duchek et al., 2001, Fulga and Rorth, 2002, Geisbrecht and Montell, 2004, Macias et al., 2004, Olofsson and Page, 2005, Zettervall et al., 2004, McDonald et al., 2006, Mathieu et al., 2007, Inaki et al., 2012, Wang et al., 2010, Wang et al., 2010, Bunt et al., 2010, Kuranaga et al., 2011, Ohsawa et al., 2011, Wang et al., 2006) | ||
| Cytology | |||
Phenotypic Data
| |||
Phenotypic Class
| |||
Phenotype Manifest In
| |||
border follicle cell & filopodium, with Scer\GAL4slbo.2.6 | |||
Detailed Description
| |||
Statement Reference Males expressing Pvr[DN.Scer\UAS] under the control of Scer\GAL4[en.PU] display mis-oriented adult genitalia, and the acceleration of genitalia rotation is significantly impaired in these flies compared to controls. Expression of Pvr[DN.Scer\UAS] under the control of Scer\GAL4[gcm-rA87.P] stalls haemocyte migration in the embryo, and anterior Malpighian tubule positioning is disrupted. The anterior pair of tubules project into the poster half of the embryo and do not take up their anterior position as in wild-type. Border follicle cells that are expressing PvrDN.Scer\UAS under the control of Scer\GAL4slbo.2.6 show mild defects in posterior migration towards the oocyte. Expression of PvrDN.Scer\UAS under the control of Scer\GAL4slbo.2.6 causes border cell misguidance defects but the penetrance of this phenotype is relatively low; only 16% of egg chambers are affected. Expression of Pvr[DN.Scer\UAS] under the control of Scer\GAL4[slbo.2.6] results in incomplete border cell migration in 25% of stage 10 egg chambers. Expression of Pvr[DN.Scer\UAS] in early hemocytes, driven by Scer\GAL4[s.gcm], disrupts the normal migration of hemocytes during embryonic development. In severe cases, the hemocytes become aggregated in the anterior part of the embryo by stage 15. At stage 17, the VNC is shorter in Pvr[DN.Scer\UAS] embryos than in wild-type, indicating that the VNC fails to condense correctly in Pvr[DN.Scer\UAS] mutants. Expression of Pvr[DN.Scer\UAS] in the lateral glia and not in hemocytes, driven by Scer\GAL4[158], does not cause either the hemocyte migration or VNC condensation phenotype. When Pvr[DN.Scer\UAS] is expressed in the mesodermal midline, driven by Scer\GAL4[sim.PS], VNC condensation is partially inhibited. Expression of PvrDN.Scer\UAS under the control of Scer\GAL4slbo.2.6 results in a mild border follicle cell migration defect. When expression is driven by Scer\GAL4dpp.blk1 or Scer\GAL4en-e16E the male terminalia are rotated. The effect is more pronounced with Scer\GAL4en-e16E than with Scer\GAL4dpp.blk1, though in both cases shows variable penetrance and expressivity. When expression is driven by Scer\GAL4He.PZ, hemocyte proliferation is decreased and lamellocyte and crystal cells numbers are unaffected. Expression of PvrDN.Scer\UAS under the control of Scer\GAL4sim.P3.7 does not result in a detectable mutant central nervous system phenotype in embryos. Hemocytes are largely clustered near the dorsal and anterior regions of the embryo in stage 16 embryos expressing PvrDN.Scer\UAS under the control of Scer\GAL4gcm.PP, in contrast to wild-type embryos where they are dispersed throughout the embryo. These embryos also show rounding of the central nervous system axon commissures and mispositioning of repo-positive glial cells. Border cells in the ovaries of PvrDN.Scer\UAS; Scer\GAL4slbo.2.6 animals form dramatically fewer long cellular extensions (20-40 μm) and significantly fewer intermediate cellular extensions (10-20 μm). When expressed under the control of Scer\GAL4slbo.2.6 some delay in posterior migration of border cells is seen. Less than 60% of border cell clusters reach the oocyte at stage 10. | |||
External Data
| |||
| Linkouts | |||
Interactions
| |||
|
|||
Phenotypic Class
| |||
Phenotype Manifest In
| |||
Enhanced by | |||
Statement Reference EgfrDN.Scer\UAS, PvrDN.Scer\UAS, Scer\GAL4slbo.2.6 has border follicle cell phenotype, enhanceable by TieDN.Scer\UAS, Scer\GAL4slbo.2.6 PvrDN.Scer\UAS, Scer\GAL4dpp.blk1 has adult external abdomen | dorsal phenotype, enhanceable by Pvf1[-] PvrDN.Scer\UAS, Scer\GAL4en-e16E has adult external abdomen | dorsal phenotype, enhanceable by Pvf1[-] PvrDN.Scer\UAS, Scer\GAL4slbo.2.6 has border follicle cell & filopodium phenotype, enhanceable by EgfrDN.Scer\UAS, Scer\GAL4slbo.2.6 PvrDN.Scer\UAS, Scer\GAL4slbo.2.6 has border follicle cell & filopodium phenotype, enhanceable by Pvf1EPg11235, Scer\GAL4slbo.2.6 PvrDN.Scer\UAS, Scer\GAL4slbo.2.6 has border follicle cell phenotype, enhanceable by EgfrDN.Scer\UAS, Scer\GAL4slbo.2.6 PvrDN.Scer\UAS, Scer\GAL4slbo.2.6 has border follicle cell phenotype, enhanceable by hepAct.Scer\UAS, Scer\GAL4slbo.2.6 PvrDN.Scer\UAS, Scer\GAL4slbo.2.6 has border follicle cell phenotype, enhanceable by pucPBac3929/pucPBac3929 PvrDN.Scer\UAS, Scer\GAL4slbo.2.6 has border follicle cell phenotype, enhanceable by TieDN.Scer\UAS, Scer\GAL4slbo.2.6 PvrDN.Scer\UAS, Scer\GAL4slbo.2.6 has border follicle cell phenotype, enhanceable by vnEPg35521, Scer\GAL4slbo.2.6 | |||
Suppressed by | |||
Statement Reference PvrDN.Scer\UAS, Scer\GAL4slbo.2.6, hepAct.Scer\UAS has border follicle cell phenotype, suppressible | partially by kaybZip.Scer\UAS, Scer\GAL4slbo.2.6 PvrDN.Scer\UAS, Scer\GAL4slbo.2.6, hepAct.Scer\UAS has border follicle cell phenotype, suppressible | partially by kaydsRNA.Scer\UAS, Scer\GAL4slbo.2.6 PvrDN.Scer\UAS, Scer\GAL4slbo.2.6, hepAct.Scer\UAS has border follicle cell phenotype, suppressible | partially by thScer\UAS.cHa, Scer\GAL4slbo.2.6 PvrDN.Scer\UAS, Scer\GAL4slbo.2.6 has border follicle cell phenotype, suppressible | partially by thScer\UAS.T:Ivir\HA1, Scer\GAL4slbo.2.6 | |||
NOT suppressed by | |||
Statement Reference PvrDN.Scer\UAS, Scer\GAL4slbo.2.6, hepAct.Scer\UAS has border follicle cell phenotype, non-suppressible by BacA\p35Scer\UAS.cHa, Scer\GAL4slbo.2.6 PvrDN.Scer\UAS, Scer\GAL4slbo.2.6 has border follicle cell phenotype, non-suppressible by Mmus\Cd8aScer\UAS.T:Avic\GFP, Scer\GAL4slbo.2.6 | |||
Enhancer of | |||
Statement Reference PvrDN.Scer\UAS, Scer\GAL4slbo.2.6 is an enhancer of border follicle cell & filopodium phenotype of EgfrDN.Scer\UAS, Scer\GAL4slbo.2.6 PvrDN.Scer\UAS, Scer\GAL4slbo.2.6 is an enhancer of border follicle cell & filopodium phenotype of Pvf1EPg11235, Scer\GAL4slbo.2.6 PvrDN.Scer\UAS, Scer\GAL4slbo.2.6 is an enhancer of border follicle cell phenotype of EgfrDN.Scer\UAS, Scer\GAL4slbo.2.6 | |||
Other | |||
Statement Reference | |||
Additional Comments
| |||
Genetic Interactions
| |||
Statement Reference Co-expression of Pvr[DN.Scer\UAS] and Egfr[DN.Scer\UAS] under the control of Scer\GAL4[slbo.2.6] results in defects in border cell migration. Border cells clusters that are mutant for Shc111-40 and also expressing PvrDN.Scer\UAS under the control of Scer\GAL4slbo.2.6 show severely impaired posterior migration. Homozygous pucPBac3929 border follicle cell clones that are also expressing PvrDN.Scer\UAS under the control of Scer\GAL4slbo.2.6 show defects in posterior migration towards the oocyte that are more severe than the migration defects seen in border follicle cells expressing PvrDN.Scer\UAS under the control of Scer\GAL4slbo.2.6 in an otherwise wild-type background.
Co-expression of hepAct.Scer\UAS enhances the severity of the posterior migration defects seen in border follicle cells that are expressing PvrDN.Scer\UAS under the control of Scer\GAL4slbo.2.6.
Homozygous bsk2 border follicle cell clones that are also expressing PvrDN.Scer\UAS under the control of Scer\GAL4slbo.2.6 show defects in migration that are more severe than border follicle cells expressing PvrDN.Scer\UAS under the control of Scer\GAL4slbo.2.6 in an otherwise wild-type background.
The border follicle cell migration defects that are seen in flies co-expressing both PvrDN.Scer\UAS and hepAct.Scer\UAS under the control of Scer\GAL4slbo.2.6 are partially suppressed by the co-expression of either kaydsRNA.Scer\UAS or kaybZip.Scer\UAS.
The border follicle cell migration defects that are seen in flies co-expressing both PvrDN.Scer\UAS and hepAct.Scer\UAS under the control of Scer\GAL4slbo.2.6 are not strongly affected by the co-expression of either JradsRNA.cBa.Scer\UAS or JraJbz.Scer\UAS.
The border follicle cell migration defects that are seen in flies co-expressing both PvrDN.Scer\UAS and hepAct.Scer\UAS under the control of Scer\GAL4slbo.2.6 are partially suppressed by the co-expression of thScer\UAS.cHa. Coexpression of EgfrDN.Scer\UAS and PvrDN.Scer\UAS, under the control of Scer\GAL4slbo.2.6, results in a strong enhancement of the border cell misguidance phenotype seen when PvrDN.Scer\UAS is expressed alone; the penetrance of the phenotype is increased from 16 to 90%. Co-expression of Tie[DN.Scer\UAS] enhances the border cell migration defects caused by expression of Pvr[DN.Scer\UAS] under the control of Scer\GAL4[slbo.2.6], such that 37-58% of stage 10 egg chambers show border cell migration defects.
Co-expression of Pvr[DN.Scer\UAS] and Egfr[DN.Scer\UAS] under the control of Scer\GAL4[c306] results in border cell migration defects. The severity of the migration defects is enhanced if the females also express Tie[DN.Scer\UAS]. The border follicle cell migration defect seen in egg chambers expressing PvrDN.Scer\UAS under the control of Scer\GAL4slbo.2.6 is suppressed by coexpression of thScer\UAS.T:Ivir\HA1 (the frequency of migration defects is less than 10% in the rescued egg chambers). Being mutant at Pvf1 enhances both the penetrance and expressivity of the PvrDN.Scer\UAS terminalia phenotype. Border cells in the ovaries of Pvf1EPg11235; PvrDN.Scer\UAS; Scer\GAL4slbo.2.6 animals form lack long cellular extensions (20-40 μm) and form only very few intermediate cellular extensions (10-20 μm). Border cells in the ovaries of EgfrDN.Scer\UAS; PvrDN.Scer\UAS; Scer\GAL4slbo.2.6 animals form lack long cellular extensions (20-40 μm) and form only very few intermediate cellular extensions (10-20 μm). EgfrDN.Scer\UAS and PvrDN.Scer\UAS, when driven by Scer\GAL4slbo.2.6, leads to a dramatic effect on border cell migration. 90% of border cell clusters migrate less than half way towards the oocyte. In 5% of egg chambers, border cell clusters are found off the direct track to the oocyte. The addition of vnEPg35521 to PvrDN.Scer\UAS (driven by Scer\GAL4slbo.2.6) leads to a strong enhancement of the border cell migration defect. Border cells do not reach the oocyte at stage 10. They usually migrate less than halfway, and are sometimes found off track. | |||
Xenogenetic Interactions
| |||
Statement Reference The effect on border cell cluster migration when all border cells co-express Pvr[DN.Scer\UAS] and Egfr[DN.Scer\UAS] under the control of Scer\GAL4[slbo.2.6] and a single border cell expresses Egfr::Hsap\EGFR[hE-E.Scer\UAS.T:Avic\GFP] have been studied. In those border cell clusters where the single Egfr::Hsap\EGFR[hE-E.Scer\UAS.T:Avic\GFP]-expressing cell is located at the front of the cluster, the cluster on average moves forward, when the Egfr::Hsap\EGFR[hE-E.Scer\UAS.T:Avic\GFP]-expressing cell is in the back, the cluster on average moves relatively more backwards. In the absence of illumination, border cells expressing Egfr[DN.Scer\UAS] and Pvr[DN.Scer\UAS] under the control of Scer\GAL4[slbo.2.6] and carrying Hsap\RAC1[PA.Q61L.Scer\UAS.T:Disc\RFP-mCherry,T:Zzzz\PT1] fail to move forward. When Hsap\RAC1[PA.Q61L.Scer\UAS.T:Disc\RFP-mCherry,T:Zzzz\PT1] is photoactivated at the rear of the border cell cluster, rearward movement is seen. When photoactivation is stopped, the border cell cluster stops moving.
Photo-inactivation of Hsap\RAC1[PA.T17N.Scer\UAS.T:Disc\RFP-mCherry,T:Zzzz\PT1] at the front of border cell clusters expressing Hsap\RAC1[PA.T17N.Scer\UAS.T:Disc\RFP-mCherry,T:Zzzz\PT1], Egfr[DN.Scer\UAS] and Pvr[DN.Scer\UAS] under the control of Scer\GAL4[slbo.2.6] results in local retraction. The border follicle cell migration defects that are seen in flies co-expressing both PvrDN.Scer\UAS and hepAct.Scer\UAS under the control of Scer\GAL4slbo.2.6 are not suppressed by the co-expression of BacA\p35Scer\UAS.cHa. The border follicle cell migration defect seen in egg chambers expressing PvrDN.Scer\UAS under the control of Scer\GAL4slbo.2.6 is not suppressed by coexpression of Mmus\Cd8aScer\UAS.T:Avic\GFP. | |||
Complementation & Rescue Data
| |||
| Comments | |||
Stocks
( 0 ) | |||
Notes on Origin
| |||
| Discoverer | |||
External Crossreferences & Linkouts
| |||
| Other Crossreferences | |||
| Linkouts | |||
Synonyms & Secondary IDs
( 2 ) | |||
| Reported As | |||
| Symbol Synonym | PvrDN.Scer\UAS PVRDN | ||
| Name Synonym | |||
| Secondary FlyBase IDs | |||
References
( 18 ) | |||
| Research paper |
| ||
| Supplementary material |
| ||
Recent Updates
External Crossreferences & Linkouts